Innovassynth Technologies (India) Ltd

₹ 157 1.98%

01 Oct - close price

About

Incorporated in 2008, Innovassynth Technologies Ltd is a Contract Research, Development and Manufacturing Organization (CRDMO) specializing in pharmaceutical intermediates, oligonucleotide building blocks and specialty chemicals.

Key Points

Business Overview:^[1]
Innovassynth Technologies is a chemistry-focused CRDMO company engaged in research, development, and manufacturing across three key verticals — pharmaceutical intermediates, oligonucleotide building blocks, and specialty chemicals. It provides end-to-end services including custom synthesis, process development, scale-up, and commercial manufacturing for global life sciences and advanced materials customers. The company's oligonucleotide vertical focuses on nucleosides and amidites used in DNA/RNA therapeutics, while the specialty chemicals vertical serves applications in polyolefins, organometallic catalysts, and semiconductor materials. ITL uses chemistry capabilities, process innovation, and manufacturing expertise, to position itself as a long-term partner for global pharmaceutical and specialty chemical companies.

Website BSE

Market Cap ₹ 1,461 Cr.
Current Price ₹ 157
High / Low ₹ 157 / 45.0
Stock P/E
Book Value ₹ 10.2
Dividend Yield 0.00 %
ROCE -16.4 %
ROE -25.7 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Promoter holding has increased by 1.34% over last quarter.

Cons

Stock is trading at 15.5 times its book value
Company has low interest coverage ratio.
Company has a low return on equity of -3.75% over last 3 years.
Debtor days have increased from 85.1 to 112 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	0.00	0.00	0.00	0.00	0.00	0.00	49.91	0.00	12.27	17.28	21.97	50.83	55.99
	0.10	0.08	0.08	0.09	0.09	0.12	38.50	0.09	27.81	28.38	26.05	44.54	41.02
Operating Profit	-0.10	-0.08	-0.08	-0.09	-0.09	-0.12	11.41	-0.09	-15.54	-11.10	-4.08	6.29	14.97
OPM %							22.86%		-126.65%	-64.24%	-18.57%	12.37%	26.74%
	0.00	0.00	0.00	0.00	0.00	-0.28	1.16	-0.01	0.09	0.09	-0.39	0.01	0.19
Interest	0.08	0.09	0.09	0.12	0.09	0.10	1.79	0.11	1.35	1.76	1.89	2.23	2.00
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	1.95	0.00	1.95	1.99	1.97	1.97	2.00
Profit before tax	-0.18	-0.17	-0.17	-0.21	-0.18	-0.50	8.83	-0.21	-18.75	-14.76	-8.33	2.10	11.16
Tax %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-4.08%	0.00%	-0.43%	-3.25%	-6.36%	-469.52%	39.61%
	-0.18	-0.17	-0.17	-0.21	-0.18	-0.50	9.19	-0.21	-18.67	-14.28	-7.80	11.95	6.74
EPS in Rs	-0.06	-0.06	-0.06	-0.07	-0.06	-0.15	2.67	-0.06	-5.43	-4.15	-0.84	1.29	0.73
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	0	0	0	0	0	0	0	0	0	0	98	102	146
	0	0	0	0	0	0	0	0	0	0	77	127	140
Operating Profit	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	22	-24	6
OPM %											22%	-24%	4.2%
	0	0	0	0	0	0	0	0	0	0	1	-0	-0
Interest	0	0	0	0	0	0	0	0	0	0	4	7	8
Depreciation	0	0	0	0	0	0	0	0	0	0	4	8	8
Profit before tax	-0	-0	-0	-0	-1	-1	-1	-1	-1	-1	16	-40	-10
Tax %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	-29%	-28%
	-0	-0	-0	-0	-1	-1	-1	-1	-1	-1	20	-29	-3
EPS in Rs	-0.08	-0.11	-0.11	-0.13	-0.18	-0.18	-0.17	-0.22	-0.22	-0.23	5.86	-3.10	-2.97
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Compounded Sales Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	135%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	74%

Stock Price CAGR
10 Years:	34%
5 Years:	57%
3 Years:	85%
1 Year:	89%

Return on Equity
10 Years:	-3%
5 Years:	-3%
3 Years:	-4%
Last Year:	-26%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	24	24	24	24	24	24	24	24	24	24	28	75
Reserves	-1	-1	-2	-2	-4	-4	-4	11	10	9	95	19
	0	1	1	1	2	2	2	3	3	4	57	113
	0	0	0	0	0	0	1	1	1	2	42	71
Total Liabilities	24	24	24	24	23	23	23	39	39	39	223	278
	0	0	0	0	0	0	0	0	0	0	129	130
CWIP	0	0	0	0	0	0	0	0	0	0	1	4
Investments	24	24	24	24	23	23	23	39	39	39	0	2
	0	0	0	0	0	0	0	0	0	0	94	143
Total Assets	24	24	24	24	23	23	23	39	39	39	223	278

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	14	-39
	0	0	0	0	0	0	0	0	0	0	-21	-9
	0	0	0	0	1	0	0	0	0	0	-5	29
Net Cash Flow	-0	-0	0	0	0	-0	-0	0	0	-0	-11	-19
Free Cash Flow	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	13	-45
CFO/OP	95%	85%	73%	48%	129%	106%	100%	84%	89%	92%	69%	160%

Ratios

Standalone / View Consolidated

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days											58	112
Inventory Days											340	530
Days Payable											281	376
Cash Conversion Cycle											117	266
Working Capital Days											129	145
ROCE %	-1%	-1%	-1%	-1%	-2%	-2%	-1%	-1%	-1%	-1%	18%	-16%

Insights

In beta

Mar 2016

Sep 2017

Mar 2019

Mar 2020

Mar 2021

Dec 2025

Top Customer Revenue Share
%

xx	xx	xx	xx	xx
xx.xx	xxx.xx				xxx.xx
					xx
					xxx
					x
					xx
					xx

Please log in to see hidden values.

Order Book (Total)
INR Crore

EU Revenue Share
%

Number of Global Customers
Number

Number of Manufacturing Plants
Number

Number of Scientists (R&D Capability)
Number

USA Revenue Share
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

2 Recently

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	36.26%	36.26%	36.26%	36.26%	31.46%	31.46%	31.46%	31.46%	31.46%	73.70%	73.70%	75.04%
	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	1.39%	1.39%	1.13%
	3.70%	3.70%	3.70%	3.70%	3.21%	3.93%	3.89%	3.89%	3.89%	1.46%	1.46%	1.12%
	60.03%	60.03%	60.02%	60.03%	65.31%	64.59%	64.64%	64.64%	64.63%	23.46%	23.46%	22.71%
No. of Shareholders	27,302	27,138	27,194	26,991	26,882	27,308	27,157	27,117	27,086	26,957	26,898	27,084

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Jun 2026
	36.40%	36.47%	36.47%	36.26%	36.26%	36.26%	36.26%	36.26%	31.46%	73.70%	75.04%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.01%	0.01%	0.01%	1.39%	1.13%
	5.78%	5.74%	5.72%	5.71%	5.57%	3.93%	3.70%	3.70%	3.89%	1.46%	1.12%
	57.81%	57.79%	57.82%	58.02%	58.17%	59.80%	60.02%	60.02%	64.64%	23.46%	22.71%
No. of Shareholders	32,801	31,621	30,186	29,665	29,114	28,234	27,668	27,194	27,157	26,898	27,084

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Innovassynth Technologies (India) Ltd

Innovassynth Technologies (India) Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Insights

Shareholding Pattern

Documents

Announcements

Annual reports

Credit ratings

Concalls